Shane Wright
Postdoctoral Researcher
E-mail: shane.wright@ki.se
Visiting address: Solnavägen 9, Biomedicum, 17165 Solna
Postal address: C3 Fysiologi och farmakologi, C3 FyFa Individanpassad medicin och läkemedelsutveckling, 171 77 Stockholm
About me
Shane C. Wright is a postdoctoral researcher supported by the Swedish
- Society for Medical Research at the Department of Physiology and
Pharmacology. He has a background in cell and molecular biology and receptor - pharmacology from the University of Toronto (HBSc), the Université Paris VI
- (MSc) and Karolinska Institutet (PhD
- supervisor: Prof. Gunnar Schulte).
- Shane received postdoctoral training at the Institute for Research in
Immunology and Cancer, Université de Montréal (supervisor: Prof. Michel - Bouvier) and has since returned to Karolinska Institutet as a senior
postdoctoral fellow under the supervision of Prof. Volker Lauschke. Postdoctoral fellow (Personalized medicine and drug development) – Karolinska Institutet (2020 – Present)
Postdoctoral fellow (Biochemistry and Molecular Medicine) – Université de- Montréal (2019 – 2020)
Doctor of Philosophy (Receptor biology and signaling) – Karolinska - Institutet (2013 – 2019)
Master of Science (Cellular and Molecular Biology) – Université Paris VI - (2010 – 2012)
Honours Bachelor of Science (Life sciences) – University of Toronto - (2005 – 2010)
Research
Shane's research focuses on better understanding the action of drugs on
- receptors known as G protein-coupled receptors (GPCRs). Emerging concepts in
- receptor pharmacology such as functional selectivity and subcellular
- signaling have so far not been explored in the context of drug discovery.
- Employing a biosensor-based approach to map signaling events in fine detail
- holds great promise for our understanding of drug efficacy and side effects.
- Combining these tools with patient-derived material will provide much needed
- insight into the individual variability of patients and the potential for
- offering better treatments in the future.
Articles
- Article: MOLECULAR THERAPY. 2024;32(9):3012-3024
- Article: MOLECULAR METABOLISM. 2024;85:101931
- Article: NATURE METABOLISM. 2024;6(7):1268-1281
- Article: BRITISH JOURNAL OF PHARMACOLOGY. 2024
- Article: SCIENCE SIGNALING. 2024;17(841):eadi4747
- Article: NATURE MICROBIOLOGY. 2024;9(5):1499-1512
- Article: NATURE COMMUNICATIONS. 2023;14(1):6243
- Journal article: IUPHAR/BPS GUIDE TO PHARMACOLOGY CITE. 2021;2021(3)
- Article: CURRENT OPINION IN STRUCTURAL BIOLOGY. 2021;69:142-149
- Article: CURRENT OPINION IN PHARMACOLOGY. 2021;59:11-18
- Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2021;118(20):e2025846118
- Article: BIOCHIMICA ET BIOPHYSICA ACTA - MOLECULAR CELL RESEARCH. 2020;1867(12):118849
- Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2020;117(35):21723-21730
- Article: NATURE COMMUNICATIONS. 2019;10(1):667
- Article: SCIENCE SIGNALING. 2018;11(559):eaar5536
- Article: NATURE COMMUNICATIONS. 2017;8(1):226
All other publications
- Preprint: BIORXIV. 2023
- Editorial comment: JOURNAL OF PHYSIOLOGY. 2023;601(8):1317-1318
- Letter: CELL RESEARCH. 2021;31(12):1311-1314
- Thesis / dissertation: 2018
- Review: TRENDS IN PHARMACOLOGICAL SCIENCES. 2018;39(9):828-842
Employments
- Postdoctoral Researcher, Department of Physiology and Pharmacology, Karolinska Institutet, 2021-2024
Degrees and Education
- Degree Of Doctor Of Philosophy, Department of Physiology and Pharmacology, Karolinska Institutet, 2019